Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Takeda Pharmaceutical Company Limited, commonly known as Takeda, is a leading player in the pharmaceutical preparation manufacturing industry, headquartered in Japan (JP). Founded in 1781, Takeda has a rich history marked by significant milestones, including its expansion into global markets and a commitment to innovative healthcare solutions.
With a strong presence in regions such as North America, Europe, and Asia, Takeda focuses on key therapeutic areas including oncology, gastroenterology, and neuroscience. The company is renowned for its core products, which are distinguished by their scientific rigor and patient-centric approach.
As a top-tier pharmaceutical manufacturer, Takeda has achieved notable recognition for its contributions to healthcare, consistently ranking among the largest pharmaceutical companies worldwide. Its dedication to research and development positions Takeda as a pioneer in delivering transformative therapies that address unmet medical needs.
76
DitchCarbon score
+34 vs industry average
Takeda’s score of 76 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Takeda?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
High
Pharmaceutical Preparation Manufacturing has above-average carbon intensity
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Takeda's reported carbon emissions
Takeda, a Pharmaceutical Preparation Manufacturing company headquartered in Japan, reported its Scope 1 and Scope 2 carbon emissions for 2025 as 246,000,000 kg CO2e and 28,000,000 kg CO2e (market-based) respectively. In 2024, Scope 1 emissions were 273,000,000 kg CO2e, and Scope 2 (market-based) were 28,000,000 kg CO2e. For 2023, these figures were 279,000,000 kg CO2e for Scope 1 and 33,000,000 kg CO2e (market-based) for Scope 2.
The company's most comprehensive emissions data is from 2022, with a total of approximately 5.61 billion kg CO2e. This includes Scope 1 emissions of 277,000,000 kg CO2e, Scope 2 (market-based) emissions of 169,000,000 kg CO2e, and Scope 3 emissions totalling approximately 2.995 billion kg CO2e. Key categories within Scope 3 for 2022 included purchased goods and services (1.954 billion kg CO2e), upstream transportation and distribution (291,000,000 kg CO2e), fuel and energy-related activities (147,000,000 kg CO2e), capital goods (196,000,000 kg CO2e), and end-of-life treatment of sold products (161,000,000 kg CO2e).
Takeda has set several ambitious climate commitments. It aims to achieve net-zero greenhouse gas emissions across its operations (Scope 1 and 2) before 2035 and across its entire value chain (Scope 1, 2, and 3) before 2040.
Takeda's Science Based Targets initiative (SBTi) commitments, verified for Takeda Pharmaceutical Company Limited, include:
- Near-term targets:
- Reduce absolute Scope 1 and 2 GHG emissions by 65% by FY2030 from a FY2016 base year.
- Reduce absolute Scope 3 GHG emissions by 25% by FY2030 from a FY2022 base year.
- Long-term targets:
- Reduce absolute Scope 1 and 2 GHG emissions by 90% by FY2035 from a FY2016 base year.
- Reduce absolute Scope 3 GHG emissions by 90% by FY2040 from a FY2022 base year.
- Overall Net-Zero Target: Achieve net-zero greenhouse gas emissions across the value chain by FY2040.
Additionally, Takeda has a previous commitment to reduce Group CO2 emissions from energy sources (Scope 1 and 2) by 30% from fiscal 2015 levels by fiscal 2030.
Assessing Takeda as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Takeda and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Takeda’s Climate Goals (2030 & 2050)
8 goals2035
90% reduction in Scope 2
Takeda Pharmaceutical Company commits to reduce absolute scope 2 GHG emissions 90% by FY2035 from a FY2016 base year.
On track90%
2030
65% reduction in Scope 2
Takeda Pharmaceutical Company commits to reduce absolute scope 2 GHG emissions 65% by FY2030 from a FY2016 base year.
On track65%
2040
Takeda Pharmaceutical Company commits to reduce absolute sco…
Takeda Pharmaceutical Company commits to reduce absolute scope 2 GHG emissions 65% by FY2030 from a FY2016 base year.
On track0%
See all 8 climate goals
Sign up to see all goals
Already have an account? Sign in now
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
10 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives
Science Based Targets Initiative
FY2030 targetSee details
Active
Carbon Disclosure Project
Sign in to view
Active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Takeda1 month ago
76
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Frequently asked questions
Common questions about Takeda’s sustainability data and climate commitments
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more